The Association Between Changes in White Matter Microstructure and Cognitive Function in Older Adults with Mild

Yuehong Qiu1, Can Jiao2

  • 1College of Psychology, Liaoning Normal University, Dalian 116082, China.

Brain Sciences
|June 26, 2026
PubMed

Insights

Mild Cognitive Impairment (MCI) in older adults is linked to widespread white matter damage, affecting cognitive functions like memory and attention. Diffusion tensor imaging reveals microstructural changes correlating with cognitive decline.

Area of Science:

  • Neuroscience
  • Gerontology
  • Medical Imaging

Background:

  • Mild Cognitive Impairment (MCI) represents a critical stage between normal aging and dementia, characterized by declines in one or more cognitive domains.
  • Standardized MCI screening tools and diagnostic criteria are lacking in China, necessitating improved assessment methods.
  • Previous research on MCI's neural mechanisms has yielded inconsistent findings regarding white matter microstructure changes, partly due to a focus on fiber orientation (FA) over density (MD).

Purpose of the Study:

  • To assess cognitive function in older adults using standardized measurement tools and NIA-AA criteria.
  • To investigate white matter microstructure alterations in MCI using Diffusion Tensor Imaging (DTI) and Tract-Based Spatial Statistics (TBSS), analyzing both Fractional Anisotropy (FA) and Mean Diffusivity (MD).
  • To explore the association between white matter integrity changes and cognitive function in individuals with MCI.

Main Methods:

  • Cognitive function was assessed using the Cognitive Function Measurement Scale for the Elderly and diagnosed via NIA-AA criteria.
  • DTI with TBSS was employed to analyze white matter integrity, examining FA for fiber orientation and MD for fiber density.
  • Correlation analyses were performed between FA/MD values in differing brain regions and cognitive test scores.

Main Results:

  • The prevalence of MCI in Shenzhen's elderly population was found to be approximately 21.54%, with affected individuals showing declines in memory, attention, language, executive function, and spatial processing.
  • DTI revealed decreased FA values across white matter tracts in the MCI group, notably in the corpus callosum, internal capsule, and cingulum. Concurrently, increased MD values were observed in tracts with reduced FA.
  • Specific regions like the cingulum (hippocampus), inferior cerebellar peduncle, and corticospinal tract showed reduced MD. Significant correlations were found between white matter microstructural changes (FA/MD) and cognitive test performance.

Conclusions:

  • Older adults with MCI exhibit widespread microstructural white matter damage and functional decline across multiple cognitive domains.
  • White matter fiber density, as indicated by MD, appears informative for understanding these microstructural alterations in MCI.
  • Diffusion biomarkers in regions such as the cingulum (hippocampus) are promising targets for further investigation in MCI research.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...